## [Web Accessibility](/accessibility "Web Accessibility") Novartis is committed to improving the accessibility and usability of our websites, ensuring that content and services are available to all visitors, regardless of their ability or the technology they are using. Our web accessibility efforts are ongoing with the eventual goal of reaching Level AA conformance within the World Wide Web Consortium (W3C) Web Content Accessibility Guidelines ([WCAG 2.1](https://www.w3.org/TR/WCAG21/)). We welcome feedback which helps improve accessibility of specific pages and our websites overall. To report a website accessibility issue, request assistance or ask a question about website accessibility please email or complete the form below. This form and email address should only be used for website accessibility reports or questions. To report side effects of Novartis medicines please visit the [report side effects page](/report). For all other questions please contact your local [Novartis office](/about/locations). Name (optional) Name Organisation (if applicable) Contact email address (if response required) Type of inquiry- None -Report accessibility issueRequest assistanceQuestion about accessibilityOther Website name or page address (URL) Comment CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. - [Print](/node/86496/printable/print) - [PDF](/node/86496/printable/pdf)